Primary and acquired drug resistance patterns of Mycobacterium tuberculosis isolates in India: A multicenter study

Journal of Infection and Public Health

Volumn 6, Issue 6, 2013, Pages 456-464

  Mathuria, Jitendra Prasad ^a,c   Samaria, Jai Kumar ^a   Srivastava, Govind Narayan ^a   Mathuria, Bharat Lal ^b   Ojha, Sanjay Kumar ^a   Anupurba, Shampa ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b District Tuberculosis Clinic   (India)

^c MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

Author keywords

Drug resistance; India; MDR; Mycobacterium tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; HUMAN; INDIA; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PUBLIC HOSPITAL; TERTIARY HEALTH CARE; TUBERCULOSIS CONTROL;

DRUG RESISTANCE; INDIA; MDR; MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; TUBERCULOSIS;

EID: 84887243727     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2013.03.003     Document Type: Article

References (42)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. J Am Med Assoc 1999, 282:677-686.
2. WHO Global tuberculosis control 2011, http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf.
3. RNTCP TB INDIA 2012, RNTCP annual status report 2012, http://tbcindia.nic.in/pdfs/TB%20India%202012-%20Annual%20Report.pdf.
4. Mathur M.L., Khatri P.K., Base C.S. Drug resistance in tuberculosis patients in Jodhpur district. Indian J Med Sci 2000, 54:55-58.
5. Hemvani N., Chitnis D.S., Bhatia G.C., Sharma N. Drug resistance among tubercle bacilli from pulmonary tuberculosis cases in central India. Indian J Med Sci 2001, 55:382-392.
6. Paramasivan C.N., Bhaskaran K., Venkataraman P., Chandrasekaran V., Narayanan P.R. Surveillance of drug resistance in tuberculosis in the state of Tamil Nadu. Indian J Tuberc 2000, 47:27-33.
7. Selvakumar N. Multidrug resistance tuberculosis. Multidrug resistance in emerging & reemerging disease 2000, 133-145. INSA/Narosa Publishing House, New Delhi. R.C. Mahajan, A. Therwatheds (Eds.).
8. WHO The WHO/IUATLD Global project on anti-tuberculosis drug resistance surveillance: anti-tuberculosis drug resistance in the world. Report no. 1. WHO/TB/97.229 1997, WHO, Geneva, Switzerland.
9. Metchock B.G., Nolte F.S., Wallace R.J. Mycobacterium. Manual of clinical microbiology 1999, 399-437. ASM Press, Washington, DC. 7th ed. P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken (Eds.).
10. Canetti G., Fox W., Khomenko A., Mahler H.T., Menon N.K., Mitchison D.A., et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Org 1969, 41:21-43.
11. Viskum K., Kok-Jensen A. Multidrug-resistant tuberculosis in Denmark 1993-1995. Int J Tuberc Lung Dis 1997, 1:299-301.
12. Kent J. The epidemiology of multidrug-resistant TB in the US. Med Clin North Am 1993, 77:s1391-s1408.
13. Santha T., Thomas A., Chandrasekaran V., Selvakumar N., Gopi P.G., Subramani R., et al. Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India. Int J Tuberc Lung Dis 2006, 10:52-57.
14. Mahadev B., Kumar P., Agarwal S.P., Chauhan L.S., Srikantaramu N. Surveillance of drug resistance to anti-tuberculosis drugs in districts of Hoogli in West Bengal and Mayurbhanj in Orissa. Indian J Tuberc 2005, 52:5-10.
15. Diguimbaye C., Hilty M., Ngandolo R., Mahamat H.H., Pfyffer G.E., Baggi F., et al. Molecular characterization and drug resistance testing of Mycobacterium tuberculosis isolates from Chad. J Clin Microbiol 2006, 44:1575-1577.
16. Pablos-Méndez A., Raviglione M.C., Laszlo A., Binkin N., Rieder H.L., Bustreo F., et al. Global surveillance for anti-tuberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 1998, 338:1641-1649.
17. Paramasivan C.N., Chandrasekhar V., Santha T., Sudarsanam N.B.M., Prabhakar R. Bacteriological investigations for short course chemotherapy under the tuberculosis programme in two districts in India. Int J Tuberc Lung Dis 1993, 74:23-27.
18. Chandrasekharan S., Jagota P., Chaudhury K. Initial drug resistance to anti-tuberculosis drugs in urban and rural district tuberculosis programme. Indian J Tuberc 1992, 39:171-176.
19. WHO The WHO/IUATLD Global Project on anti-tuberculosis drug resistance surveillance: anti-tuberculosis drug resistance in the world. Report no. 2. Prevalence and trends. WHO/CDS/TB/2000.275 2000, Geneva, Switzerland.
20. WHO The WHO/IUATLD Global project on anti-tuberculosis drug resistance surveillance. Report 3. WHO/HTM/TB/2004.343 2004, WHO, Geneva, Switzerland.
21. WHO The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 2002-2007 2008.
22. Espinal M.A., Laszlo A., Simonsen L., Boulahbal F., Kim S.J., Reniero A., et al. Global trends in resistance to antituberculosis drugs. N Engl J Med 2001, 344:1294-1303.
23. Paramasivan C.N., Venkataraman P., Chandrasekaran V., Bhat S., Narayanan P.R. Surveillance of drug resistance in tuberculosis in two districts of South India. Int J Tuberc Lung Dis 2002, 6:479-484.
24. Malhotra B., Pathak S., Vyas L., Katoch V.M., Srivastava K., Chauhan D.S., et al. Drug susceptibility profiles of Mycobacterium tuberculosis isolates at Jaipur. Indian J Med Microbiol 2002, 20:76-78.
25. Urassa W., Mugusi F., Villamor E., Msamanga G., Moshiro C., Bosch R., et al. Primary antimicrobial resistance among Mycobacterium tuberculosis isolates from HIV seropositive and HIV seronegative patients in Dar es Salaam Tanzania. BMC Res Notes 2008, 1:58. 10.1186/1756-0500-1-58.
26. Bruchfeld J., Aderaye G., Palme I.B., Bjorvatn B., Ghebremichael S., Hoffner S., et al. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol 2002, 40:1636-1643.
27. Tudo G., Gonzalez J., Obama R., Rodriguez J.M., Franco J.R., Espasa M., et al. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology. Int J Tuberc Lung Dis 2004, 8:15-22.
28. Kuaban C., Bercion R., Noeske J., Cunin P., Nkamsse P., Ngo N.S. Anti-tuberculosis drug resistance in the West Province of Cameroon. Int J Tuberc Lung Dis 2000, 4:356-360.
29. Asiimwe B.B., Ghebremichael S., Kallenius G., Koivula T., Joloba M.L. Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban Kampala, Uganda. BMC Infect Dis 2008, 8:101. 10.1186/1471-2334-8-101.
30. Wei-wei J., Igor M., Gui-zhi S., Mo L., Jia-wen L., Olga N., et al. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin Med J 2007, 120:814-819.
31. Sophia V., Balasangameshwara V.H., Jagannath P.S., Kumar P. Initial drug resistance among tuberculosis patients under DOTS programme in Bangalore city. Indian J Tuberc 2004, 51:17-21.
32. Anuradha B., Aparna S., Hari Sai Priya V., Vijaya Lakshmi V., Akbar Y., Suman Latha G., et al. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003. Int J Tuberc Lung Dis 2006, 10:58-62.
33. Shah A.R., Agarwal S.K., Shah K.V. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Int J Tuberc Lung Dis 2002, 6:1098-1101.
34. Trivedi S.S., Desai S.G. Primary anti-tuberculosis drug resistance and acquired rifampicin resistance in Gujarat, India. Tubercle 1988, 69:37-42.
35. Dam T., Isa M., Bose M. Drug-sensitivity profile of clinical Mycobacterium tuberculosis isolates: a retrospective study from a chest-disease institute in India. J Med Microbiol 2005, 54:269-271.
36. Vijay S., Balasangameshwara V.H., Jagannatha P.S., Saroja V.N., Shivashankar B., Jagota P. Retreatment outcome of smear positive tuberculosis cases under DOTS in Bangalore City. Indian J Tuberc 2002, 49:195-204.
37. Jain N.K., Chopra K.K., Prasad G. Initial and acquired isoniazid and rifampicin resistance to Mycobacterium tuberculosis and its implication for treatment. Indian J Tuberc 1992, 39:121-124.
38. Vasanthakumari R., Jagannath K. Multidrug resistant tuberculosis: a Tamil Nadu study. Lung India 1997, 15:178-180.
39. Paramasivan C.N., Venkataraman P. Drug resistance in tuberculosis in India. Indian J Med Res 2004, 120:377-386.
40. Barat D., Kumar G. Prevalence and pattern of acquired drug resistance in tuberculosis including MDRTB in Bihar. J Assoc Physician India 2003, 51:332.
41. Datta M., Radhamani M.P., Selvaraj R., Paramasivan C.N., Gopalan B.N., Sudendra C.R., et al. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tuberc Lung Dis 1993, 74:180-186.
42. WHO The WHO/IUATLD Global Working Group on anti tuberculosis drug resistance surveillance. Guidelines for surveillance of drug resistance in tuberculosis. WHO/TB/96.216 1996, WHO, Geneva, Switzerland.